FDA
approval
· 2022-12-23
FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (ONESOURCE SPECIALTY PHARMA LIMITED)
Summary
FDA approved an original application for mycophenolate mofetil, a generic immunosuppressant used to prevent organ transplant rejection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)